HLS Therapeutics, Inc. (HLS.TO)
3.71
+0.01
(+0.27%)
CAD |
TSX |
Nov 13, 16:00
HLS Therapeutics Price : 3.71 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 3.70 | 3.73 | 3.51 | 3.71 | 172776.0 |
| Nov 12, 2026 | 4.14 | 4.14 | 3.70 | 3.70 | 89830.00 |
| Nov 11, 2026 | 4.40 | 4.40 | 4.10 | 4.19 | 37125.00 |
| Nov 10, 2026 | 4.37 | 4.37 | 4.13 | 4.15 | 33069.00 |
| Nov 09, 2026 | 4.50 | 4.50 | 4.34 | 4.37 | 14865.00 |
| Nov 06, 2026 | 4.46 | 4.48 | 4.39 | 4.41 | 11408.00 |
| Nov 05, 2026 | 4.49 | 4.50 | 4.26 | 4.44 | 56190.00 |
| Nov 04, 2026 | 4.49 | 4.49 | 4.22 | 4.25 | 39598.00 |
| Nov 03, 2026 | 4.48 | 4.69 | 4.20 | 4.23 | 56660.00 |
| Nov 02, 2026 | 4.49 | 4.62 | 4.41 | 4.47 | 10905.00 |
| Oct 30, 2026 | 4.51 | 4.55 | 4.38 | 4.51 | 35743.00 |
| Oct 29, 2026 | 4.55 | 4.67 | 4.49 | 4.56 | 158109.0 |
| Oct 28, 2026 | 4.57 | 4.58 | 4.45 | 4.56 | 11532.00 |
| Oct 27, 2026 | 4.43 | 4.63 | 4.43 | 4.57 | 10922.00 |
| Oct 26, 2026 | 4.30 | 4.50 | 4.29 | 4.46 | 23184.00 |
| Oct 23, 2026 | 4.14 | 4.34 | 4.08 | 4.33 | 125900.0 |
| Oct 22, 2026 | 4.13 | 4.15 | 4.12 | 4.15 | 7100.00 |
| Oct 21, 2026 | 4.15 | 4.15 | 4.09 | 4.13 | 13102.00 |
| Oct 20, 2026 | 4.13 | 4.19 | 4.10 | 4.15 | 23771.00 |
| Oct 19, 2026 | 4.14 | 4.14 | 4.08 | 4.09 | 4649.00 |
| Oct 16, 2026 | 4.19 | 4.20 | 4.06 | 4.10 | 15342.00 |
| Oct 15, 2026 | 4.24 | 4.24 | 4.11 | 4.14 | 41098.00 |
| Oct 14, 2026 | 4.05 | 4.17 | 4.05 | 4.10 | 19178.00 |
| Oct 13, 2026 | 4.24 | 4.24 | 4.03 | 4.05 | 25650.00 |
| Oct 09, 2026 | 4.17 | 4.35 | 4.09 | 4.09 | 142079.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bausch Health Cos., Inc. | 11.91 |
| Cipher Pharmaceuticals, Inc. | 14.17 |
| BioSyent, Inc. | 17.79 |
| Revive Therapeutics Ltd. | 0.015 |
| Knight Therapeutics, Inc. | 12.06 |
Price Related Metrics
| PS Ratio | 1.465 |
| Price to Book Value | 1.551 |
| Price to Free Cash Flow | 5.010 |
| Earnings Yield | -8.26% |
| Market Cap | 116.01M |